In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Theratase PLC

Division of Abbott Laboratories Inc.

Latest From Theratase PLC

Recent Dealmaking (04/2004)

Summarizing the month in European dealmaking.

AM-Pharma BV

AM-Pharma BV, a Dutch start up firm, is trying to harness the body's innate ability to fight infection. The company has three programs based on its antimicrobial peptide technology platform and has recently merged with compatriot PharmAAware Sepsis BV to pursue the use of alkaline phosphatase as a treatment for sepsis and other infection-inspired inflammatory disorders.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Glucose Testing
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Enviromed PLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • John Chesham , PhD, CEO
    Colin Anderson , Dir., Fin.
  • Contact Info
  • Theratase PLC
    Phone: (44) 020 7 863 8819
    11-12 Waterloo Place
    Trafalgar House
    London, SW1Y 4AU